Exact Mass: 408.0891572

Exact Mass Matches: 408.0891572

Found 42 metabolites which its exact mass value is equals to given mass value 408.0891572, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetracenomycin E

C22H16O8 (408.0845136)

Tetracenomycin B2

8-Demethyltetracenomycin A2

C22H16O8 (408.0845136)

Ethyl biscoumacetate

Ethyl 2,2-bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetic acid

C22H16O8 (408.0845136)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

3,5,7,4-Tetrahydroxy-3-(5-formyl-2-hydroxyphenyl)flavanone

3,5,7,4-Tetrahydroxy-3- (5"-formyl-2"-hydroxyphenyl) flavanone

C22H16O8 (408.0845136)

Anhydromaggiemycin

C22H16O8 (408.0845136)

Prostalidin B

C22H16O8 (408.0845136)

Torosaflavone C

(5bR,8aS)-rel-4H,5b,8a-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-methyl-8H-cyclopenta[4,5]furo[3,2-g]-1-benzopyran-4,8-dione

C22H16O8 (408.0845136)

8-p-Hydroxybenzylquercetin

3,5,7,3,4-Pentahydroxy-8- (p-hydroxybenzyl) flavone

C22H16O8 (408.0845136)

3,5,7-Trihydroxy-2,3-dihydro-2-(2,2-dihydroxy-5-formyl[1,1-biphenyl]-5-yl)-4H-1-benzopyran-4-one

C22H16O8 (408.0845136)

9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one

C22H16O8 (408.0845136)

C22H16O8

C22H16O8 (408.0845136)

methyl eriodermate

C20H21ClO7 (408.09757460000003)

pericosine E

C16H21ClO10 (408.0823196)

SCHEMBL17866783

C22H16O8 (408.0845136)

3-chloro-9beta,15-dihydroxy-8beta-tiglinoyloxy-dehydrleucodin

C20H21ClO7 (408.09757460000003)

Cys Asp Asp Gly

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)

Cys Asp Gly Asp

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]acetamido}butanedioic acid

C13H20N4O9S (408.095095)

Cys Gly Asp Asp

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carboxypropanamido]butanedioic acid

C13H20N4O9S (408.095095)

Asp Cys Asp Gly

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C13H20N4O9S (408.095095)

Asp Cys Gly Asp

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]acetamido}butanedioic acid

C13H20N4O9S (408.095095)

Asp Asp Cys Gly

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)

Asp Asp Gly Cys

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C13H20N4O9S (408.095095)

Asp Gly Cys Asp

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-sulfanylpropanamido]butanedioic acid

C13H20N4O9S (408.095095)

Asp Gly Asp Cys

(3S)-3-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)

Gly Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C13H20N4O9S (408.095095)

Gly Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C13H20N4O9S (408.095095)

Gly Asp Asp Cys

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)

4-[4,5-DIHYDRO-5-(1H-INDOL-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-BENZENESULFONAMIDE

C18H15F3N4O2S (408.0867766)

flavanthrone

C28H12N2O2 (408.0898732)

2,6-dimethoxy-4-methyl-8-nitro-5-[3-(trifluoromethyl)phenoxy]quinoline

C19H15F3N2O5 (408.0933016)

1,4-Bis(7-chloroquinolin-4-yl)piperazine

C22H18Cl2N4 (408.09084479999996)

3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide

C19H22O6P2 (408.0891572)

N10-(Trifluoroacetyl)pteroic acid

C16H11F3N6O4 (408.0793842)

Disperse Yellow 114

C20H16N4O4S (408.08922160000003)

Leriglitazone hydrochloride

C19H21ClN2O4S (408.0910496000001)

C78272 - Agent Affecting Nervous System Leriglitazone (MIN-102; Hydroxypioglitazone) hydrochloride, a metabolite of pioglitazone. Leriglitazone hydrochloride PioOH is a PPARγ agonist, stabilizes the PPARγ activation function-2 (AF-2) co-activator binding surface and enhances co-activator binding, affording slightly better transcriptional efficacy. Leriglitazone hydrochloride binds to the PPARγ C-terminal ligand-binding domain (LBD) with a Ki of 1.2 μM，Leriglitazone induces transcriptional efficacy of the PPARγ (LBD) with an EC50 of 680 nM[1].